Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization

World Journal of Gastroenterology

Volumn 9, Issue 10, 2003, Pages 2344-2347

  Bai, Yui Jie ^a   Zhao, Jin Rong ^a   Lv, Guan Ting ^a   Zhang, Wen Hong ^a   Wang, Yan ^a   Yan, Xiao Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DNA FRAGMENT; DYE; LAMIVUDINE; METHIONINE; PRIMER DNA; TYROSINE; VIRUS DNA;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA SEQUENCE; DNA TEMPLATE; FLUORESCENCE POLARIZATION; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MIXED INFECTION; MODEL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; RECOMBINANT PLASMID; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; VIRUS MUTANT; WILD TYPE;

EID: 0142213383     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i10.2344     Document Type: Article

References (19)

1. Yan JC, Ma JY, Pan BR, Ma LS. The study of chronic hepatitis B in China. Shijie Huaren Xiaohua Zazhi 2001; 9: 611-616
2. Su Q, Fu Y, Liu YF, Zhang W, Liu J, Wang CM. Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture. World J Gastroenterol 2003; 9: 921-929
3. Cao XY, Liu J, Lian ZR, Clayton M, Hu JL, Zhu MH, Fan DM, Feitelson M. Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. World J Gastroenterol 2001; 7: 575-578
4. Huang YX, Wu GH. The relationship between hepatitis B and hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2001; 9: 682-685
5. Wang FS, Xing LH, Liu MX, Zhu CL, Liu HG, Wang HF, Lei ZY. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001; 7: 537-541
6. Han HL, Lang ZW. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World J Gastroenterol 2003; 9: 117-121
7. Lai YC, Hu RT, Yang SS, Wu CH. Coinfection of TT virus and response to interferon therapy in patients with chronic hepatitis B or C. World J Gastroenterol 2002; 8: 567-570
8. Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L. Preliminary results of Thymosin-α1 versus interferon-a-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001; 7: 407-410
9. You J, Zhuang L, Tang BZ, Yang WB, Ding SY, Li W, Wu RX, Zhang HL, Zhang YM, Yan SM, Zhang L. A randomized controlled clinical trial on the treatment of Thymosin α1 versus interferon-α in patients with hepatitis B. World J Gastroenterol 2001; 7: 411-414
10. Cheng ML, Wu YY, Huang KF, Luo TY, Ding YS, Lu YY, Liu RC, Wu J. Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-alpha(1) and traditional medicine preparation. World J Gastroenterol 1999; 5: 267-269
11. Zoulim F. A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection. Drug Saf 2002; 75: 497-510
12. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B. World J Gastroenterol 2002; 8: 868-871
13. Han T, Qian SC, Chen Y, Xiao SX, Wang FM, Han ZC, Lu HM. Treatment of 198 patients with chronic hepatitis B with lamivudine and Yi-Gan-Jian. Shijie Huaren Xiaohua Zazhi 2002; 10: 1236-1237
14. Lai CL, Diestag J, Schiff E, Leung NW, Atkins M, Hunt C, Brown N, Woessner M, Boehme R, Condreay L. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003; 36: 687-696
15. Cao H, Tao P. Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro. Zhonghua Yixue Zazhi 2001; 81: 1004-1007
16. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341: 1256-1263
17. Li G, Shu X, Ma HH, Chen W, Chen WS, Chen Q, Jiang YS, Yao JL. Detection of HBV, HCV and HBV YMDD mutants by DNA microarray. Shijie Huaren Xiaohua Zazhi 2003; 11: 178-181
18. Hsu TM, Chen X, Duan S, Miller RD, Kwok PY. Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques 2001; 31: 560-568
19. Jardi R, Buti M, Rodriguez-Frias F, Cotrina M, Costa X, Pascual C, Esteban R, Guardia J. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. J Virol Methods 1999; 83: 181-187